Supira Medical

Great presentation today by Dr. Ricardo Costa during the #TCT2024 Interventional Heart Failure #Innovation session! Preliminary results from Supira Medical's Early Feasibility Study support safety and feasibility of the Supira System in #HRPCI. The Supira System is for investigational use only and is not for sale in the U.S. or outside the U.S. #pVAD #medtech #makingadifference 

Exciting week ahead for Supira Medical at #TCT2024! Don't miss these three sessions highlighting our next generation low profile, high continuous flow #pVAD device. The Supira System is for investigational use only and is not for sale in the U.S. or outside the U.S. #innovation #medtech #makingadifference 

Exciting week ahead for Supira Medical at #TCT2024! Don't miss these three sessions highlighting our next generation low profile, high continuous flow #pVAD device. The Supira System is for investigational use only and is not for sale in the U.S. or outside the U.S. #innovation #medtech #makingadifference 

Thank you to Dr. Ricardo Costa and his team - Rodolfo Staico, MD, PhD, Louis Ohe and Rafael Battilani - from Instituto Dante Pazzanese de Cardiologia - IDPC for showcasing the Supira Medical #pVAD in a fantastic Live in a Box Case presentation today at #SOLACI2024!  #cardiovascular #innovation #medtech #startup #makingadifference

Supira Medical is excited to be attending #SOLACI2024 this week in Buenos Aires! Stop by to see us at booth PA1 on the exhibit floor and don't miss Dr. Ricardo Costa's Live in a Box Case highlighting our novel #pVAD to support #HRPCI during the "Coronary Heart Disease Learning Session - Innovation: New Devices, New Solutions, New Tools for the Future in IC" starting at 3:10pm in Atlantico Room A on Thursday, August 8th.  #cardiovascular #innovation #medtech #startup #makingadifference

Supira Medical is honored to be a part of the PA MedTech VC Fund and congratulates the Picard Angst team on a successful first close of Fund II! Our team is making excellent progress as we remain laser focused on achieving our next clinical and regulatory milestones.  #pVAD #cardiovascular #medtech #startup #makingadifference

The momentum continues for Supira Medical's podium presence with an excellent presentation by Dr. Tai Pham at #CVI2024 highlighting the company's novel #pVAD. In this compelling case study, Dr. Pham noted how Supira’s high-flow low-profile system remained stable during the procedure while providing full hemodynamic support for the #HRPCI patient.  Azeem Latib, Gagan Singh #innovation #cardiovascular #medtech #startup #makingadifference

That's a wrap on #EuroPCR! The Supira team had an excellent week meeting with physicians and colleagues to discuss how Supira's low profile, high continuous flow #pVAD aims to provide full hemodynamic support for a broad range of patients with a single device platform. Through #innovation, we are helping to advance cardiovascular care together.  #medtech #cardiovascular #makingadifference 

Fantastic presentation this morning by Dr. Alexandre Abizaid at #PCR2024 highlighting the initial 30 subjects treated in Supira Medical's South America (SA) feasibility study. Dr. Abizaid reported the Supira System provided successful hemodynamic support throughout the #HRPCI, met primary safety and efficacy endpoints with no events of hemolysis reported in this feasibility study. With this encouraging signal of safety and efficacy, Supira looks forward to initiating a larger study to further validate its innovative #pVAD technology. Don't forget to swing by Booth M39 to see the Supira System for yourself!  #innovation #medtech #cardiovascular #makingadifference

Looking forward to an exciting week ahead for Supira Medical at #PCR2024! Don't miss Dr. Alexandre Abizaid present the clinical results from the initial 30 subjects treated as part of Supira's South America (SA) feasibility study with 30-day follow up during tomorrow's Mechanical Circulatory Support in Cardiogenic Shock and High Risk #PCI abstract session, 11:45-13:15 in Room 341. And be sure to stop by Booth M39 to learn more about Supira's low profile, high continuous flow #pVAD.  #innovation #medtech #cardiovascular #makingadifference